BlackRock Health Sciences Trust (NYSE:BME) Stock Price Crosses Below Two Hundred Day Moving Average – Here’s Why

BlackRock Health Sciences Trust (NYSE:BME)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $40.52 and traded as low as $39.27. BlackRock Health Sciences Trust shares last traded at $39.6150, with a volume of 63,351 shares trading hands.

BlackRock Health Sciences Trust Stock Performance

The firm’s 50 day moving average is $39.19 and its 200 day moving average is $40.52.

BlackRock Health Sciences Trust Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, June 15th will be paid a dividend of $0.2621 per share. The ex-dividend date of this dividend is Monday, June 15th. This represents a c) annualized dividend and a yield of 7.9%.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of hedge funds and other institutional investors have recently bought and sold shares of BME. Royal Bank of Canada grew its stake in BlackRock Health Sciences Trust by 0.5% in the 1st quarter. Royal Bank of Canada now owns 143,546 shares of the company’s stock worth $5,546,000 after buying an additional 684 shares in the last quarter. Jones Financial Companies Lllp purchased a new position in BlackRock Health Sciences Trust in the 1st quarter worth approximately $386,000. Invesco Ltd. grew its stake in BlackRock Health Sciences Trust by 0.5% in the 2nd quarter. Invesco Ltd. now owns 201,788 shares of the company’s stock worth $7,357,000 after buying an additional 1,047 shares in the last quarter. First Trust Advisors LP grew its stake in BlackRock Health Sciences Trust by 108.1% in the 2nd quarter. First Trust Advisors LP now owns 14,930 shares of the company’s stock worth $544,000 after buying an additional 7,754 shares in the last quarter. Finally, NewEdge Advisors LLC grew its stake in BlackRock Health Sciences Trust by 8.5% in the 2nd quarter. NewEdge Advisors LLC now owns 14,185 shares of the company’s stock worth $517,000 after buying an additional 1,111 shares in the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.